[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH

被引：0
|
作者：
A. Afshar-Oromieh
U. Haberkorn
M. Eder
M. Eisenhut
CM. Zechmann
机构：
[1] University Hospital Heidelberg,Department of Nuclear Medicine
[2] German Cancer Research Center,Department of Radiopharmaceutical Chemistry
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2012年 / 39卷
关键词：
Prostate Cancer; Positron Emission Tomography; Androgen; Ligand Binding; Urinary Bladder;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1085 / 1086
页数：1
相关论文
共 50 条
  • [11] Comment on Afshar-Oromieh et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
    Reske, Sven Norbert
    Winter, Gordon
    Baur, Benjamin
    Machulla, Hans-Juergen
    Kull, Thomas
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (06) : 969 - 970
  • [12] Comment on Afshar-Oromieh et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
    Sven Norbert Reske
    Gordon Winter
    Benjamin Baur
    Hans-Jürgen Machulla
    Thomas Kull
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 969 - 970
  • [13] [68GA]GALLIUM LABELLED LIGANDS OF THE PROSTATE SPECIFIC MEMBRANE ANTIGEN AS NOVEL VALIDATED PET-TRACER FOR THE DIAGNOSIS OF PROSTATE CANCER
    Boxler, Silvan
    Kuru, Timur
    Afshar-Oromieh, Ali
    Hohenfellner, Markus
    Haberkorn, Uwe
    Hadaschik, Boris
    JOURNAL OF UROLOGY, 2013, 189 (04): : E901 - E901
  • [14] Comparison of PET imaging with a 68Ga-labelled PSMA ligand versus 18F-choline PET/CT for the diagnosis of Prostate Cancer & Radioprotection for involved personnel
    Zeinab Khansa
    Mohamad B. Haidar
    Nemer Neaimeh
    Mahmoud Korek
    Health and Technology, 2019, 9 : 607 - 613
  • [15] Comparison of PET imaging with a 68Ga-labelled PSMA ligand versus 18F-choline PET/CT for the diagnosis of Prostate Cancer & Radioprotection for involved personnel
    Khansa, Zeinab
    Haidar, Mohamad B.
    Neaimeh, Nemer
    Korek, Mahmoud
    HEALTH AND TECHNOLOGY, 2019, 9 (04) : 607 - 613
  • [16] (68Ga) gallium-PSMA PET/CT in the evaluation of prostate cancer patients
    Bal, C.
    Ballal, S.
    Tripati, M.
    Chakraborty, P.
    Thakral, P.
    Arora, G.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56
  • [17] Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer
    Dietlein, Markus
    Kobe, Carsten
    Kuhnert, Georg
    Stockter, Simone
    Fischer, Thomas
    Schomaecker, Klaus
    Schmidt, Matthias
    Dietlein, Felix
    Zlatopolskiy, Boris D.
    Krapf, Philipp
    Richarz, Raphael
    Neubauer, Stephan
    Drzezga, Alexander
    Neumaier, Bernd
    MOLECULAR IMAGING AND BIOLOGY, 2015, 17 (04) : 575 - 584
  • [18] MR PET scan with 68GA PSMA in prostate cancer
    Lo, R.
    Lo, C.
    Chan, J.
    Cheung, W.
    Lo, G.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 84 - 85
  • [19] MR PET scan with 68Ga PSMA in prostate cancer
    Lo, R. K.
    Lo, C. S.
    Chan, J. K.
    Cheung, W. S.
    Lo, G. G.
    BJU INTERNATIONAL, 2017, 119 : 7 - 7
  • [20] Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer
    Markus Dietlein
    Carsten Kobe
    Georg Kuhnert
    Simone Stockter
    Thomas Fischer
    Klaus Schomäcker
    Matthias Schmidt
    Felix Dietlein
    Boris D. Zlatopolskiy
    Philipp Krapf
    Raphael Richarz
    Stephan Neubauer
    Alexander Drzezga
    Bernd Neumaier
    Molecular Imaging and Biology, 2015, 17 : 575 - 584
12345